Table 4.
Baseline viral load (IU/ml) | IL-28B SNP | OR (95 % CI) | p-Value | |
---|---|---|---|---|
CC rs12979860 | CT–TT rs12979860 | |||
≥600,000 | 12 (37.5 %) | 20 (62.5 %) | 5.40 (1.68–17.38) | 0.003 |
<600,000 | 5 (10.0 %) | 45 (90.0 %) | ||
≥800,000 | 5 (26.3 %) | 14 (73.7 %) | 1.52 (0.46–5.04) | 0.493 |
<800,000 | 12 (19.0 %) | 51 (81.0 %) | ||
TT rs8099917 | TG–GG rs8099917 | |||
≥600,000 | 18 (56.2 %) | 14 (43.8 %) | 2.50 (1.00–6.21) | 0.047 |
<600,000 | 17 (34.0 %) | 33 (66.0 %) | ||
≥800,000 | 9 (47.4 %) | 10 (52.6 %) | 1.28 (0.46–3.59) | 0.638 |
<800,000 | 26 (41.3 %) | 37 (58.7 %) | ||
AA rs12980275 | AG–GG rs12980275 | |||
≥600,000 | 10 (31.2 %) | 22 (68.8 %) | 3.33 (1.07–10.36) | 0.032 |
<600,000 | 6 (12.0 %) | 44 (88.0 %) | ||
≥800,000 | 5 (26.3 %) | 11 (17.5 %) | 1.69 (0.50–5.67) | 0.509 |
<800,000 | 14 (73.7 %) | 52 (82.5 %) |
CI confidence interval; OR odds ratio